A detailed history of Virtus ETF Advisers LLC transactions in Novavax Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 21,884 shares of NVAX stock, worth $200,895. This represents 0.14% of its overall portfolio holdings.

Number of Shares
21,884
Previous 15,228 43.71%
Holding current value
$200,895
Previous $72,000 284.72%
% of portfolio
0.14%
Previous 0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $25,891 - $139,576
6,656 Added 43.71%
21,884 $277,000
Q1 2024

May 15, 2024

SELL
$3.76 - $6.02 $3,921 - $6,278
-1,043 Reduced 6.41%
15,228 $72,000
Q4 2023

Feb 15, 2024

BUY
$4.8 - $7.67 $16,598 - $26,522
3,458 Added 26.99%
16,271 $78,000
Q3 2023

Nov 07, 2023

SELL
$6.81 - $9.74 $8,662 - $12,389
-1,272 Reduced 9.03%
12,813 $92,000
Q2 2023

Aug 14, 2023

BUY
$6.67 - $9.52 $54,774 - $78,178
8,212 Added 139.83%
14,085 $104,000
Q1 2023

May 15, 2023

SELL
$5.76 - $12.48 $12,994 - $28,154
-2,256 Reduced 27.75%
5,873 $40,000
Q4 2022

Feb 14, 2023

BUY
$8.86 - $25.04 $48,162 - $136,117
5,436 Added 201.86%
8,129 $83,000
Q3 2022

Nov 14, 2022

BUY
$18.2 - $76.12 $254 - $1,065
14 Added 0.52%
2,693 $49,000
Q2 2022

Aug 12, 2022

BUY
$36.28 - $75.29 $63,780 - $132,359
1,758 Added 190.88%
2,679 $138,000
Q1 2022

May 16, 2022

SELL
$69.73 - $142.9 $3,765 - $7,716
-54 Reduced 5.54%
921 $68,000
Q4 2021

Feb 14, 2022

SELL
$134.56 - $217.97 $7,131 - $11,552
-53 Reduced 5.16%
975 $139,000
Q3 2021

Nov 15, 2021

SELL
$177.8 - $270.58 $8,712 - $13,258
-49 Reduced 4.55%
1,028 $213,000
Q2 2021

Aug 10, 2021

SELL
$121.0 - $257.67 $148,951 - $317,191
-1,231 Reduced 53.34%
1,077 $229,000
Q1 2021

May 17, 2021

BUY
$112.98 - $319.93 $3,728 - $10,557
33 Added 1.45%
2,308 $418,000
Q4 2020

Feb 12, 2021

SELL
$78.74 - $139.5 $353,621 - $626,494
-4,491 Reduced 66.38%
2,275 $254,000
Q3 2020

Nov 13, 2020

SELL
$79.44 - $178.51 $73,561 - $165,300
-926 Reduced 12.04%
6,766 $733,000
Q2 2020

Aug 05, 2020

BUY
$13.86 - $83.61 $106,611 - $643,128
7,692 New
7,692 $641,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $718M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.